| Mr Willem Diederik Coetzee
| Mr Willem Diederik Coetzee is CEO in Kibo Mining PLC. He also serves as Board Member at BOC Ltd - Kenya. Mr Coetzee owns 3.47% in Kibo Mining PLC since December 2012. |
| Mr Christian Schaffalitzky
| Mr Christian Schaffalitzky was a Chairman of Kibo Mining PLC to Jan 2022. He owns 8.7% in Kibo Mining PLC since December 2012. |
| Mr Rory John O Keeffe
| Mr Rory John O Keeffe was Managing Director of Guinness PLC - Nigeria between 01 November 2014 and 30 June 2015. |
| Mr Flemming Ornskov
| Mr Flemming Ornskov is CEO at Shire PLC. Mr Flemming Ornskov has been Chairman of the Supervisory Board of Evotec since August 2008. He is a well known executive with extensive experience within the pharmaceutical industry. As Global President of Pharmaceuticals at Bausch & Lomb, Dr Ornskov is responsible for the company's prescription ophthalmic pharmaceuticals and generics, as well as its OTC business. Most recently, Dr Ornskov was CEO and President of LifeCycle Pharma, an emerging cardiovascular and transplantation specialty company. Prior, he served as CEO and President of biotech start-up Ikaria, Inc., which was sold to a private equity company within a year of him taking office. From 2002 to 2005, he was President of the Ophthalmics Business Unit for Novartis and from 2001 to 2002, he led Novartis' US cardiovascular franchise. Prior to joining Novartis, Dr Ornskov held multiple leadership positions at Merck & Co. Dr Ornskov serves on several boards, and is Chairman of the board for Santaris Pharma A/S and Astion Pharma A/S. Dr Ornskov received a MD degree from the University of Copenhagen, a MBA degree from INSEAD and a Master of Public Health degree from Harvard University. |
| Mr Iskandar Akef Najjar
| Member of the Board of Directors Alpari ME DMCC |
| Mr Cecil Bond
| Cecil Bond, VP of Finance since March 2010; Director of the Company from December 2009 to September 2010; Chief Financial Officer of Exeter Resource Corporation since April 2005; Chartered Accountant. Since 1996 to present Director, and at various times President, CEO and CFO of Argosy Minerals Inc.; CFO of Rugby Mining Limited (formerly Carlyle Mining Corp.) from February 2007 to March 2009; Director of Rugby Mining Limited since March 2009; Director and officer of various private companies. |
| Mr Susan Kilsby
| Ms Susan Kilsby is Chairman of Shire PLC. Ms Susan Kilsby was appointed to the Board on September 1, 2011 and is a member of the Audit, Compliance & Risk Committee. Ms Kilsby brings to the Board extensive M&A and finance experience. She is a Non-Executive Director of BBA Aviation plc and was a Director of Hong Kong listed global skin care company, L'Occitane International S.A until December 2012. Ms. Kilsby has had a distinguished global career in investment banking having held senior positions with The First Boston Corporation, Bankers Trust, Barclays de Zoete Wedd and most recently Credit Suisse where she was Chairman of the EMEA Mergers & Acquisitions team until 2009 and continues in a part-time senior advisory capacity. Ms. Kilsby holds a BA in Economics and a MBA. |
| Ms Anne Minto
| Ms Anne Minto is Non Executive Director at Shire PLC on June 16, 2010 and is Chairman of the Remuneration Committee and a member of the Nomination Committee. Ms. Minto brings to the Board her extensive legal, commercial and remuneration experience. She is a Non-Executive Director of Tate & Lyle PLC and is a former Director of Northumbrian Water plc and SITA UK. Ms. Minto held the position of Group Director, Human Resources at Centrica plc from October 2002 to 30 June 2011 and was a member of the Centrica Executive Committee. Her extensive business career includes senior management roles at Shell UK, the position of Deputy Director-General of the Engineering Employers' Federation and the position of Group Director Human Resources at Smiths Group plc. Following her law degree at Aberdeen University and a post graduate diploma in Human Resources she qualified as a lawyer. Ms. Minto is a Fellow of the Chartered Institute of Personnel & Development, the Royal Society of Arts and the London City and Guilds and a Member of Law Society of Scotland. She is a trustee of the University of Aberdeen Development Trust and is Patron of the University of Aberdeen Alumni Fund. |
| Mr William Burns
| Mr William Burns was appointed to the Board on March 15, 2010 and is a member of the Remuneration Committee, the Nomination Committee and of the Science & Technology Committee. Mr. Burns brings to the Board extensive experience in international sales, marketing, integration and operational experience in the pharmaceutical sector. He is a Director of Biotie Therapies Corp., Roche Holdings Ltd, Chugai Pharmaceutical Co., Ltd and Genentech, Inc. and is a former Director of Crucell N.V. Mr. Burns worked for many years for Roche, holding the position of CEO of their pharmaceuticals division from 2005 to 2009 and was a member of the Roche Group Corporate Executive Committee. Mr. Burns holds a BA (Hons). |
| Mr David Ginsburg
| Mr David Ginsburg was appointed to the Board on June 16, 2010 at Shire PLC. and is a member of the Science & Technology Committee. Dr. Ginsburg brings to the Board his clinical medical background in Internal Medicine, Hematology-Oncology, and Medical Genetics, as well as his extensive basic biomedical laboratory research expertise. He is currently James V. Neel Distinguished University Professor of Internal Medicine Human Genetics, and Pediatrics at the University of Michigan and a Howard Hughes Medical Institute Investigator. Dr. Ginsburg obtained his BA at Yale University, MD at Duke University and completed his medical and research training at Harvard Medical School, before joining the faculty at the University of Michigan. Dr. Ginsburg is the recipient of numerous honors and awards, including election to membership in the National Academy of Sciences, the Institute of Medicine and the American Academy of Arts and Sciences. |
| Mr David Kappler
| Mr David Kappler has been a member of the Board since April 5, 2004. He was appointed Senior Independent Non-Executive Director in July 2007 and Deputy Chairman in June 2008 at Shire PLC. He is also Chairman of the Nomination Committee and of the Audit, Compliance & Risk Committee. Mr. Kappler brings to the Board his extensive knowledge and experience in financial reporting, risk management and internal financial controls. He is a Non-Executive Director of InterContinental Hotels Group plc. He was Chairman of Premier Foods plc until September 2010 and held directorships at Camelot Group plc and HMV Group plc. Mr. Kappler retired from Cadbury Schweppes plc in April 2004 after serving as Chief Financial Officer since 1995. He worked for the Cadbury Schweppes Group between 1965 and 1984 and rejoined the company in 1989 following its acquisition of the Trebor Group, where he was Financial Director. Mr. Kappler is a Fellow of the Chartered Institute of Management Accountants. |
| Mr Olivier Bohuon
| Mr Olivier Bohuon joined the Board and appointed Chief Executive Officer in April 2011. Mr Olivier is Non Executive Director at Shire PLC. He has had extensive international experience within a number of pharmaceutical and healthcare companies. Prior to joining Smith & Nephew, he was President of Abbott Pharmaceuticals, a division of Abbott Laboratories based in the US, where he was responsible for the entire business, including R&D, Global Manufacturing and global support functions. Other Directorships; Non-Executive Director of Virbac Group. |
| Ms Sara Mathew
| Ms Sara Mathew was elected to the Board of Directors in 2005, and serves on the Audit Committee and Compensation and Organization Committees. In January of 2010, she was appointed President and Chief Executive Officer of The Dun & Bradstreet Corporation, and in July of 2010, she assumed the role of Chief Executive Officer and Chairman of the Board. Ms. Mathew brings to Campbell valuable insight and experience in global business and financial matters. Before assuming her current role at Dun & Bradstreet, she served as President and Chief Operating Officer of that company from 2007 to 2009; President, U.S. from 2006 to 2007; President, International in 2006; and Chief Financial Officer from 2001 to 2007. In her preceding 18-year career at Procter & Gamble, she held a number of executive positions, including Vice President of Finance with responsibility for Australia, Asia and India, and a series of finance and marketing positions, including Assistant Treasurer and Director of Investor Relations, Comptroller for the Paper Products division, and Comptroller and Chief Financial Officer of the Global Baby Care business unit. The Dun & Bradstreet Corporation (2008 to present). She also serves as Non Executive Director at Shire PLC. |
| Mr Bernard Poznanski
| Bernie Poznanski, Corporate Secretary. Lawyer, Koffman Kalef Business Lawyers. |
